Metaiodobenzylguanidine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Metaiodobenzylguanidine, covering 2025-12-03 to 2025-12-03. Get the full timeline:
Most recent: Clinical Trial Update: NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab [Phase 2]